Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

31.24
Delayed Data
As of 3:57pm ET
 -0.06 / -0.19%
Today’s Change
25.55
Today|||52-Week Range
35.04
+14.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues5.7B5.4B5.3B5.1B
 
 
 
 
 
Cost of Goods Sold400.3M436.2M485.7M752.1M
 
 
 
 
 
Depreciation And Amortization534.6M561.5M563.1M537.8M
 
 
 
 
 
 
Operating ExpensesGross Income4.8B4.4B4.2B3.8B
 
 
 
 
 
General Expenses3.7B4.1B3.1B2.2B
 
 
 
 
 
Research And Development1.4B1.3B1.2B1.4B
 
 
 
 
 
Total Operating Expenses4.7B5.1B4.2B3.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.1B230.5M1.1B1.6B
 
 
 
 
 
Extraordinary Credit0.000.0022.1M0.00
 
 
Extraordinary Charge-290.3M-454.4M-407.3M-366.5M
 
 
 
 
 
Interest Expense On Debt147.5M151.1M160.3M301.7M
 
 
 
 
 
Equity In Earnings-3.8M-7.7M-9.2M-10.0M
 
 
 
 
 
Other Expenses51.7M353.9M98.6M1.0B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income683.1M-21.0M632.2M2.0B
 
 
 
 
 
Income Taxes-92.1M-956.6K-294.0M-333.6M
 
 
 
 
 
Minority Interest-19.7M-26.8M-17.5M-22.8M
 
 
 
 
 
Net Income607.0M-2.9M934.4M1.7B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.24$0.00$0.37$0.67
 
 
 
 
EPS Diluted$0.24-$0.00$0.37$0.66